Sickle Clinical Flashcards

1
Q

clinical aspects of sickle cell disease

A
  • group of disorders with sickle hemoglobin (HbS) in the homozygous or doubly heterozygous (HbS and HbC) state causes disease
  • HbS mutation results in polymerization of HbB upon deoxygenation causing increased RBC destruction and anemia and blockage of capillaries causing pain and/or organ dysfunction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

frequency and severity

A
  • 1/400 african americans have sickle cell disease which is often life threatening
  • average life-span close to 50 for females and just over 45 for males
  • 30%)
  • compare to 1/3000 incidence of CF in US pop
  • in real world patient care, racism plays a very large role
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

clinical severity

A
  • depends on type of sickle cell disease
  • even within a type, great variation in severity
  • ~20% of patients have ~80% of complications while the rest have a relatively mild disease
  • cause of clinical variability still poorly understood
  • likely related to other genotypes-RBC or WBC adhesion
  • high WBC may inc risk of disease
  • improved ability to predict more sever disease may better guide therapy and decrease morbidity/mortality
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

initial diagnosis: newborn screening

A
  • fetal HbF >90% newborns Hg in general
  • unaffected by sickle mutation and protects newborn for first 3-4 months
  • in past Dx made when complications arose
  • some infants died of bacterial sepsis since Dx unknown and fever not managed appropriately
  • NB screening in USA allows Dx, education, and prophylactic antibiotics prior to risk of sepsis, decreasing morbidity and mortality
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

native gel

A
  • how newborn blood is screen
  • Hg with different charges separated
  • B6 mutation takes neg Glu to neutral Val-shift in electric migration
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

sickle cell trait

A
  • AS
  • carrier state in 8-10% of African Americans
  • 55-65% HbA, 25-45% HbS
  • clinical complications are very rare
  • main issue is genetic implications
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

homozygous sickle cell anemia

A
  • > 2/3 patients and most form of severe sickle cell disease

- both parents AS- 25% risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Hb SC disease

A
  • one parent AS and other AC
  • AC found in 2-3% African Americans
  • C also defect of beta6 Glu-Lys
  • C does not sickle but increases Hb viscosity
  • 1/4 patients, milder disease
  • 50% S and 50% C, no A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

sickle cell beta thalassemia

A
  • HbS from sickle gene, little or no HbA from ineffective beta thal gene
  • 1 parent AS trait, 1 parent thal trait
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

bacterial sepsis

A
  • splenic vasooclusion inhibits bacterial clearance
  • encapsulated bacteria (pneumococcus) in previously unexposed children require splenic clearance-but can’t do it
  • risk begins at 4 months, 15% incidence without penicillin prophylaxis
  • frightening complication
  • 30-50% mortality
  • 2/3 of deaths within 8 hours of 1st symptoms
  • most common cause of death <5 years of age
  • penicillin prophylaxis, aggressive antibiotic Rx of fever (usually ceftraiaxone), immunization greatly decrease risk
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

painful vaso occlusive episode

A
  • most common complication throughout life
  • not clear why they are so episodic and unpredictable, usually lasting a few days
  • hand foot syndrome often in 1st and 2nd years of life
  • episodes can involve almost any area
  • pain can be excruciating and often need narcotics
  • doses still often inadequate
  • morphine patient controlled analgesia best
  • respiratory depression and addiction are rare
  • supportive care
  • pain control, fluids, ensure oxygenation, control fever, transfusion not usually helpful
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

stroke

A
  • 10% develop stoke with unilateral weakness
  • acute unpredictable onset usually in child
  • long term neurologic deficits&raquo_space;death
  • RBC transfusions as Rx and prophylaxis
  • exchange transfusion acutely
  • chronic RBC transfusions to prevent recurrence (without, 70% recur)
  • indication for bone marrow transplant
  • stroke prevention with transcranial doppler
  • high cerebral arterial flow rates predict risk
  • prevent 80% of strokes with annual studies ages 2-16 years
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

acute chest syndrome

A
  • unique term for acute lung disease in sickle cell
  • includes-infection, vasoocclusion, fat embolus
  • most common cause of death >5 yrs of age and can cause chronic lung disease in adults
  • antibiotics, oxygenation, incentive spirometry, transfusion acutely if more severe and occasionally chronically to prevent recurrance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

acute splenic sequestration crisis

A
  • sudden enlargement of the spleen due to acute vasoocclusion
  • occurs in 1st 5 years of life and can rapidly result in hypovolemic shock
  • acute treatment involves fluid resuscitation and transfusion
  • teaching parents splenic palpation reduces mortality
  • listen to the family
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

genetic counseling

A

-obligation to empower parents to make their own decisions
-study both parents-electrophoresis for Hbs and blood count, determine risk of SS, SC, S beta thal
-if at risk, prenatal diagnosis via amnio
-preimplantation genetics
harvest placental cord blood from newborn sibling for safest possible transplant to cure affected sibling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

overview of therapy

A
  • traditionally mainly supportive-hydration, pain Rx, oxygenation, transfusions
  • specific-hydroxyurea-mild chemotherapeutic-HbF
  • no serious toxicity, risk of pain and chest syndrome dec by 50%, decreases mortality, ongoing daily Rx
17
Q

“cure”

A
  • bone marrow transplant
  • requires HLA identical sib
  • 25% of full sibs HLA dependent-14 % in real life
  • with HLA exact-5% mortality and 10-15% morbidity- best with umbilical blood
  • long term complications remain a concern
18
Q

who should undergo transplant?

A
  • risk benefit critical
  • CVA or risk for CVA
  • frequent debilitating pain
  • recurrent and severe acute chest syndrome
  • ?future risk factor analysis to allow transplant prior to complications occuring
19
Q

bone marrow transplantation

A
  • use of unrelated GLA to allow wider use causes increases in mortality, but getting better
  • unrelated cord blood may work
  • readily available without any morbidity, more stem cells and less immunologic reactivity allow significant HLA mismatch and less GVH
  • use of non HLA identical cords in trials
20
Q

future

A
  • develop effective viral vector to insert normal beta chain via benign viral illness without immunosuppression of transplant
  • some progress but transmitted gene does not exist
21
Q

our report card

A
  • rx limited, cure available to too few
  • many MDs know little about the disease and Rx
  • racism remains a real issue
  • US mortality as low as <2% by age 10 vs 30% by age 3 historically
  • survival in jamaica is better than US
  • within US, mortality 10X greater in florida than maryland
  • tremendous PH failure